Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1279049-31-8

Post Buying Request

1279049-31-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1279049-31-8 Usage

General Description

The chemical compound (2R,3S)-2-amino-3-hydroxy-4,4-dimethylpentanoic acid is an amino acid derivative, specifically a derivative of the amino acid leucine. It is a chiral molecule, meaning it has two enantiomers (2R,3S) and (2S,3R). (2R,3S)-2-aMino-3-hydroxy-4,4-diMethylpentanoic acid is involved in various biological processes, including protein synthesis and energy production. It is also a component of some antibiotics and has potential therapeutic applications in the treatment of metabolic disorders. Additionally, it is an important intermediate in the synthesis of pharmaceuticals and agrochemicals. Overall, (2R,3S)-2-amino-3-hydroxy-4,4-dimethylpentanoic acid plays a crucial role in biochemical and pharmaceutical research.

Check Digit Verification of cas no

The CAS Registry Mumber 1279049-31-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,7,9,0,4 and 9 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1279049-31:
(9*1)+(8*2)+(7*7)+(6*9)+(5*0)+(4*4)+(3*9)+(2*3)+(1*1)=178
178 % 10 = 8
So 1279049-31-8 is a valid CAS Registry Number.

1279049-31-8Upstream product

1279049-31-8Downstream Products

1279049-31-8Relevant articles and documents

Disubstituted beta-lactones as inhibitors of N-acylethanolamine acid amidase (NAAA)

-

Page/Page column 139, (2016/06/28)

The present invention provides compounds and pharmaceutical compositions for inhibiting N-acylethanolamine acid amidase (NAAA). Inhibition of NAAA is contemplated as a method to sustain the levels of palmitoylethanolamide (PEA) and oleylethanolamide (OEA), two substrates of NAAA, in conditions characterized by reduced concentrations of PEA and OEA. The invention also provides methods for treating inflammatory diseases and pain, and other disorders in which decreased levels of PEA and OEA are associated with the disorder.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1279049-31-8